Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Bruker (BRKR) Free Cash Flow (2016 - 2026)

Bruker filings provide 16 years of Free Cash Flow readings, the most recent being $207.2 million for Q4 2025.

On a quarterly basis, Free Cash Flow rose 35.16% to $207.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $43.3 million, a 68.16% decrease, with the full-year FY2025 number at $43.3 million, down 68.16% from a year prior.
Free Cash Flow hit $207.2 million in Q4 2025 for Bruker, up from -$54.1 million in the prior quarter.
In the past five years, Free Cash Flow ranged from a high of $207.2 million in Q4 2025 to a low of -$148.8 million in Q2 2025.
Median Free Cash Flow over the past 5 years was $14.5 million (2022), compared with a mean of $37.9 million.
Biggest five-year swings in Free Cash Flow: plummeted 8800.0% in 2022 and later skyrocketed 9650.0% in 2025.
Bruker's Free Cash Flow stood at $110.2 million in 2021, then rose by 24.23% to $136.9 million in 2022, then rose by 27.1% to $174.0 million in 2023, then dropped by 11.9% to $153.3 million in 2024, then soared by 35.16% to $207.2 million in 2025.
The last three reported values for Free Cash Flow were $207.2 million (Q4 2025), -$54.1 million (Q3 2025), and -$148.8 million (Q2 2025) per Business Quant data.